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Sebaceous carcinoma (SC) is a rare malignant neoplasm usually presenting as an ocular lesion or, less
commonly, an extraocular cutaneous lesion mostly on the head and neck, whereas it seldom found on
other sites. We present a case of a 56-year-old woman with SC on her left nipple. To our knowledge, this
is the second reported SC arising in the nipple, but may be the ﬁrst case of SC of the nipple displaying
predominance in intraepidermal proliferation with superﬁcial dermal invasionda very seldom described
growth pattern of extraocular SC in literature. An early invasive stage of the rare intraepidermal variant is
suggested, with the location of the originating tumor cells being different from that of the usual intra-
dermal cases. Free/ectopic sebaceous gland is one of the possible origins.
Copyright  2013, Taiwanese Dermatological Association.
Published by Elsevier Taiwan LLC. All rights reserved.Introduction
Sebaceous carcinoma (SC) is a rare, potentially aggressive malig-
nancy demonstrating exclusive sebocytic differentiation with un-
known etiology. It accounts for less than 1% of all cutaneous
malignancies, and is traditionally subcategorized into two groups
based on the site of origin: ocular (periocular) and extraocular. In
spite of the widespread anatomic distribution of sebaceous glands,
extraocular SC is less common than its ocular counterpart
(comprising about 25% of all reported cases of SCs) and most
commonly presents in the 6th and 7th decades of life on the head
and neck where sebaceous glands are most plentiful. Other re-
ported primary sites of extraocular SC include the external geni-
talia, parotid and submandibular glands, buccal mucosa, external
auditory canal, trunk, extremities, breast, laryngeal or pharyngeal
cavities, and lung.1e5 SC arising in the nipple has been only once
reported.6
Histopathologically, extraocular SC typically shows a variably
organoid but asymmetric “intradermal” proliferation of inﬁltrative
lobules/nests of atypical oval/polyhedral cells with variable degrees
of sebaceous differentiation typiﬁed by vacuolated or multi-
vesicular/foamy cytoplasm with occasionally scalloped nucleary have no ﬁnancial or non-
tter or materials discussed in
e, Hsinchu Mackay Memorial
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iwanese Dermatological Associatiocontour. The particular vacuolization must be distinguished from
the usual simple cytoplasmic clarity.7 A variety of histological fea-
tures can exist in SC, e.g., multinodularity, comedo-type necrosis,
pagetoid spread into the overlying epithelium/epidermis, and car-
cinoma in situ; the latter two features have been occasionally
depicted in the literature, but are more commonly found in the
ocular type than in the extraocular type.4,8,9 Extraocular SCs with
only/mainly intraepidermal growth (intraepidermal SCs) are
extremely rare.10e12
Rarely, SC occurs in Muir-Torre syndrome (MTS), with at least an
associated visceral malignancy (usually a gastrointestinal carci-
noma, occurs less in other organs) that may precede or follow the
SC. Therefore, SC sometimes is a diagnostic sign of MTS.13
Case report
A 56-year-old woman visited a surgical clinicianwith a ﬁrm, mildly
eroded, gradually enlarging light yellow nodule measuring about
0.5 cm located eccentrically on her left nipple, which had been
noticed a few weeks earlier (Figure 1). She had no other cutaneous
tumor, breast tumor, regional lymphadenopathy, or any clinical
evidence of other internal malignancy.
Histopathologically, the lesion in the partially excised nipple
(cut into 3 sections) showed mainly intraepidermal proliferation
in a broad zone of the basal part of the epidermis, with many large
and occasionally connecting blunt bulbous downward extensions
(only slightly more than 1 mm in depth) composed of atypical/
hyperchromatic oval germinative cells, frequently owning clear to
ﬁne multivesicular cytoplasm with various degrees of sebaceousn. Published by Elsevier Taiwan LLC. All rights reserved.
Figure 1 Clinical photograph of the left nipple nodule in a 56-year-old woman (note
the eccentric location).
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features of holocrine secretion/abortive sebaceous ducts
(Figure 2A, B, C and D). The mature neoplastic sebocytes, differ-
entiating/transitional cells, and immature germinative cells were
haphazardly arranged with a variable ratio; the average ratio was
about 1:2:2. The tumor cells possessed atypical round to irregular
vesicular nuclei with obvious nucleoli and occasional scalloped
nuclear membrane, and exhibited sporadic necrosis and frequent
mitoses [counting from 1 to 6 in most high-power ﬁelds (HPFs),
about 20/10 HPFs on average]. Focally there were some small nests
of atypical sebocytes invading the upper dermis (Figure 2C and E)
but no prominent haphazard intradermal growth of invasive tu-
mor lobules. No aggregations of uniform basaloid cells with pe-
ripheral palisading and retraction artifact from stroma were seen.
Few individual and small clusters of tumor cells showed a page-
toid feature in the epidermis, while the epidermis lacked atypical
keratinocytes. No lymphaticecapillary permeation was found.
Many tumor cells showed immunoreactivity for cytokeratin (CK) 7
(OV-TL 12/30; Dako) and epithelial membrane antigen (EMA)
(E29; Dako), with more intensity in those fairly or frankly differ-
entiated tumor cells (Figure 3A); some tumor cells were positive
for CD15 (Carb-3; Dako); a minority of tumor cells were positive
for humen epithelial antigen (Ber-EP4, Dako) and CK5/6 (D5/16
B4; Dako); and none were positive for carcinoembryonic antigen
(CEA) (II-7; Dako) or gross cystic disease ﬂuid protein 15
(GCDFP-15) (23A3; Dako). CK5/6 also more intensely stained the
basalesuprabasal layers of epidermis and highlighted the residual
normal basal cells in the lower periphery of the intraepidermal
tumor growth (Figure 3B). The proliferative fraction as detected by
Ki-67 staining (MIB-1; Dako) was greater than 20% in some HPFs.
There was a high percentage of tumor cell staining for p53 (DO-7;
Dako), about 50% on average (Figure 3C). In addition, many tumor
cells were positive for androgen receptor (AR441; Dako). The
immunohistochemical (IHC) study was performed with Dako
Autostainer Link48 and the provided ready-to-use antibodies; the
antibodies for CK7, EMA, Ber-EP4, CK5/6, CEA, Ki-67, and p53 were
produced by Dako Denmark A/S (Glostrup, Denmark); the others
were produced by Dako North America (Carpinteria, CA, USA).
Based on the particular pathological ﬁndings, we made a diagnosis
of SC that was predominant in intraepidermal proliferation with
superﬁcial dermal invasion.
The lesion was completely removed. Our patient did not un-
dergo lymph node dissection. She had no recurrence of tumor or
metastasis during the 23 months of follow-up, and she did not
show clinical evidence of MTS either. The subsequent available IHC
analysis for expression of DNA mismatch repair gene products(proteins) related to MTS revealed expression of MutL protein
homolog 1 (MLH-1) (ES05; Dako North America) and MutS protein
homolog 2 (MSH-2) [G219-1129; Roche-Ventana, Rocklin, CA, USA;
performed with BenchMark XT (Ventana, Tucson, Ariz, USA)], with
diffuse strong MLH-1 staining (Figure 3D) and partial reduction in
MSH-2 staining.
Discussion
Clinically, extraocular SC often appears as a pink to red-yellow
nodule, but can exhibit diverse clinical presentations and is
commonly confused with other lesions, especially basal cell carci-
noma (BCC) and squamous cell carcinoma (SCC). The tumor may
appear on top of pre-existing dermatoses, like nevus sebaceous,
actinic keratosis, and Bowen’s disease.4,14,15 SC arising in the nipple
is much rarer than other types of nipple tumors, such as Paget’s
disease and nipple duct adenoma, which may appear similar in
clinical images.
On pathological examination, IHC stains are often less necessary
for distinguishing SC frommost cutaneous tumors. Identiﬁcation of
the characteristic histologic featuredthe multivesicular appear-
ance of tumor cellsdis beneﬁcial to differentiating SC from the
more common tumors of other lineages with simple cytoplasmic
clarity, such as BCC, pagetoid variant of Bowen’s disease, SCC,
poroma/porocarcinoma, trichilemmal tumor, and Paget’s disease.7
However, the following facts may render the differential diag-
nosis difﬁcult: (1) sebaceous differentiation may be rarely found in
the less/poorly differentiated cases; (2) sebaceous differentiation
can be focally encountered in other types of cutaneous tumors, like
SCC, BCC, and trichoblastoma; (3) there are some cases/variants of
SC (e.g., the basaloid) with other feature(s) similar to that of the
other cutaneous tumors, e.g., superﬁcial epithelioma with seba-
ceous differentiation, sebaceous adenoma, sebaceoma, and BCC
with sebaceous differentiation; (4) similar foamy cytoplasm can be
seen in the rare signet-ring cell variant of melanoma.
The key points formaking a differential diagnosis have beenwell
described in the textbooks and literature. We will focus on those
encountered in diagnosing the case displaying, as ours, predomi-
nance in intraepidermal proliferationwith blunt bulbous downward
extensions and superﬁcial dermal invasion. The frequent classical
multivesicular cytoplasm/sebaceous differentiation, occasional ho-
locrine secretion, the absence of dysplastic keratinocytes in the
overlying epidermis, the absence of pagetoid growth of tumor cells
in thewhole thickness of epidermis, and frequent stainingwith CK7
and androgen receptor in the tumor cells of our case are helpful in
making a diagnosis of SC rather than SCC and invasive carcinoma
arising inBowen’s diseasewith sebaceousdifferentiation.15 (CK7has
been reported inpagetoid Bowen’s disease but not in the other types
of SCC.16) Sebaceoma is well circumscribed: it has bland basaloid
cells with some blandmature sebocytes, it stains in a similar way to
sebaceous adenoma and hyperplasia, and it has statistically signiﬁ-
cant lower expression levels of p53 compared to SC (11% versus 50%,
respectively) and Ki-67 (10% versus 30%, respectively).17 The
prominent blunt bulbous downward growth pattern, apparent nu-
clear atypia of neoplastic sebocytes andgerminative/immature cells,
disordered arrangement of kinds of tumor cells without peripheral
palisading, high p53 level, and frequent mitoses in our case all
render the diagnosis of malignancy and help to distinguish it from
superﬁcial epitheliomawith sebaceous differentiation andBCCwith
sebaceous differentiation. Paget’s disease and some melanomas
tend to have marked intraepithelial spread and pale to sometimes
vacuolated cytoplasm. However, they express clinical features, his-
tologicﬁndings, and immunophenotypesmuchdifferent from those
of SC. The IHC stain for adipophilin, another sensitive and fairly
speciﬁc marker said to be useful especially in diagnosing poorly
Figure 2 (A) Low-power view of two of three sections of the specimen showing tumor growth involving broad horizontal dimension of the epidermis with only slightly more than
1 mm in depth of tumor growth [hematoxylin and eosin (H&E); original magniﬁcation, 30]. (B) Low-power view of the third section of the tumor showing the predominant
intraepidermal proliferation with large blunt downward extensions containing mainly hyperchromatic immature cells in the left ﬁeld and more differentiated pale cells in the right
ﬁeld [H&E; original magniﬁcation, 50]. (C) High-power view of the red square in Figure 2B showing aggregations of atypical germinative cells with mildly pleomorphic vesicular
nuclei, distinct nucleoli, frequent mitoses, and mild sebaceous differentiation, but no peripheral palisading or retraction artifact from stroma. Also note the small isolated clusters of
atypical differentiated sebocytes in the right lower ﬁeld [H&E; original magniﬁcation, 400]. (D) High-power view of extending aggregations/nests in one section in Figure 2A
revealing hyperchromatic oval cells with frequent sebaceous differentiation. There is presence of three foci with some features of holocrine secretion/abortive sebaceous ducts (red
circles), with absence of dysplastic keratinocytes in the overlying epidermis and absence of pagetoid growth of tumor cells in the whole thickness of the epidermis (H&E; original
magniﬁcation, 200). (E) Small nests of atypical sebocytes in the dermal papillae and the presence of a small portion of sebaceous ducts near some intraepidermal atypical
sebocytes are shown in the lower left corner (red circle) (H&E; original magniﬁcation, 500).
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not indispensable to our case, which reveals apparent sebaceous
differentiation. Finally, another important differential diag-
nosisdcutaneous spreading from an underlying sebaceous carci-
noma of the breast parenchyma/duct can be ruled out due to lack of
tumor in the underlying breast tissue and the excised lactiferous
ducts in our case.
Except for a few anatomic sites, the sebaceous glands are hair
follicle-associated intradermal structures, therefore, extraocular SC
(thought to arise from the sebaceous gland) will generally present as
a dermal tumor, as expected. It also seems reasonable that cases of
extraocular SC with intraepidermal spread (other than pagetoid
pattern) into and/or carcinoma in situ change in the overlying
epidermis will be unusual or only has such phenomenon in a focal/
limited area, let alone the cases with purely intraepidermal growth
(called intraepidermalSCsor the thusqualiﬁed “SC in situ”).However,
the latter do exist, although extremely rarely.4,8,10,12 On review of the
description and ﬁgures of the reported extraocular intraepidermalSCs/SC in situ, we note that the intraepidermal growth, as predomi-
nant as in our case, basically shows expanding aggregations of tumor
cells in the lower part of the epidermis. In our case, besides the few
small inﬁltrative tumor nests, those deep blunt extensions from the
epidermis (only slightly more than 1 mm in depth) might be
considered, by some authors, to be invasive. Nevertheless, this tumor
can be regarded as only superﬁcially invasive, andwe intend to use a
special diagnostic term “intraepidermal SC with superﬁcial dermal
invasion” to reﬂect its actual growth features, progression manner,
and distinctive clinicopathological character, which are different
from those of usual invasive SCs. Cibull et al did not mention the
intraepidermal proliferation in their case, but basedon their image of
it,we considered thepossibilityof an initial intraepidermal growth in
such an exophytically enlarged nipple tumor.6
Owing to the scarcity of intraepidermal SC/SC in situ and rare
association with usual extraocular SC, some authors think that the
intraepidermal SC/SC in situ may not be the precursor of the latter.
In clinical practice, however, one should always consider the
Figure 3 Immunohistochemical features. (A) Frank EMA positivity in many tumor cells (original magniﬁcation, 125). (B) Weak to fair staining of CK5/6 in some tumor cells and
strong staining of the residual normal basalesuprabasal cells of the epidermis were evident. Note one non-neoplastic sebaceous gland at the bottom (original magniﬁcation, 125).
(C) Moderate to strong nuclear staining for p53 in more than 50% of tumor cells (original magniﬁcation, 200). (D) Retained diffuse strong nuclear staining for MLH-1 (original
magniﬁcation, 150).
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situ is seen.1,8,10e12 Furthermore, intraepidermal SC/SC in situ will
eventually become invasive if untreated; but this kind of SC, to
which our case belongs, may own a unique histogenesis different
from that of common invasive cases initially growing intradermally.
Apart from considering the origination from pluripotent cells in the
basal layer of epidermis, as suggested by some authors,15 we pre-
sume another possible derivation from certain sebaceous-
committed germinative cells situated in or shortly below the
basal layer of the epidermisdi.e., cells in the superﬁcially-located
free/non-hair follicle-associated or ectopic sebaceous glands such
as those seen on the lip/buccal mucosa, labia minor, prepuce, and
the nippleeareola complex; the latter contains free glands either in
the Montgomery’s tubercles or widely covering the surface.
Treatment involving entire excision of the lesion of SC with
removal of any lymph nodes that are affected is recommended.
However, the standard treatment for such a superﬁcially invasive
case as ours is not yet proposed due to the small number of cases.
The retained expression of MLH-1 and MSH-2, which are lost in
most internal malignancy-associated sebaceous neoplasms in MTS,
suggests that underlying MTS is unlikely in our patient. The partial
reduction rather than complete loss of MSH-2 staining, as seen in
many reported cases without MTS, does not indicate increased risk
of visceral malignancies.17,19
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